US2009227649A1PendingUtilityA1

Management of Ophthalmologic Disorders, Including Macular Degeneration

60
Assignee: HARVARD COLLEGEPriority: Feb 17, 2004Filed: Dec 31, 2008Published: Sep 10, 2009
Est. expiryFeb 17, 2024(expired)· nominal 20-yr term from priority
Inventors:Robert R. Rando
C07C 243/38C07C 211/45C07C 49/203C07C 217/86C07C 233/25C07C 45/68C07D 203/08C07C 2601/16C07C 403/20C07C 403/10A61P 27/02C07D 303/08C07C 229/60C07C 403/16C07C 43/162C07C 403/08C07C 251/40C07C 43/15C07C 403/18C07C 403/12C07C 229/56C07C 233/05C07C 57/26C07C 233/09C07C 69/24C07B 2200/09C07C 2601/14
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A drug may be used in the preparation of a medicament for the treatment or prevention of an ophthalmologic disorder, wherein the drug inhibits, antagonizes, or short-circuits the visual cycle at a step of the visual cycle that occurs outside a disc of a rod photoreceptor cell.

Claims

exact text as granted — not AI-modified
1 . Use of a drug in the preparation of a medicament for the treatment or prevention of an ophthalmologic disorder, wherein the drug inhibits, antagonizes, or short-circuits the visual cycle at a step of the visual cycle that occurs outside a disc of a rod photoreceptor cell. 
   
   
       2 - 294 . (canceled)

Join the waitlist — get patent alerts

Track US2009227649A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.